EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A peptidomimetic modulator of the Ca V 2.2 N-type calcium channel for chronic pain

Kimberly Gomez iD, Ulises Santiago, Tyler S Nelson, Heather N Allen, Aida Calderon-Rivera iD, Sara Hestehave iD, Erick J Rodríguez Palma iD, Yuan Zhou, Paz Duran iD, Santiago Loya-Lopez, Elaine Zhu iD, Upasana Kumar iD und 25 weitere

Proceedings of the National Academy of Sciences · 21.11.2023 · 120 (47)

DOI: 10.1073/pnas.2305215120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 16.11.2023. Verfasst von Kimberly Gomez und 36 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pathobiology, College of Dentistry, New York University, New York, NY 10010. Hauptthemen laut MEDLINE: Chronic Pain, Peptidomimetics. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, NINDS NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transmembrane Ca v 2.2 (N-type) voltage-gated calcium channels are genetically and pharmacologically validated, clinically relevant pain targets. Clinical block of Ca v 2.2 (e.g., with Prialt/Ziconotide) or indirect modulation [e.g., with gabapentinoids such as Gabapentin (GBP)] mitigates chronic pain but is encumbered by side effects and abuse liability. The cytosolic auxiliary subunit collapsin response mediator protein 2 (CRMP2) targets Ca v 2.2 to the sensory neuron membrane and regulates their function via an intrinsically disordered motif. A CRMP2-derived peptide (CBD3) uncouples the Ca v 2.2–CRMP2 interaction to inhibit calcium influx, transmitter release, and pain. We developed and applied a molecular dynamics approach to identify the A 1 R 2 dipeptide in CBD3 as the anchoring Ca v 2.2 motif and designed pharmacophore models to screen 27 million compounds on the open-access server ZincPharmer. Of 200 curated hits, 77 compounds were assessed using depolarization‐evoked calcium influx in rat dorsal root ganglion neurons. Nine small molecules were tested electrophysiologically, while one (CBD3063) was also evaluated biochemically and behaviorally. CBD3063 uncoupled Ca v 2.2 from CRMP2, reduced membrane Ca v 2.2 expression and Ca 2+ currents, decreased neurotransmission, reduced fiber photometry-based calcium responses in response to mechanical stimulation, and reversed neuropathic and inflammatory pain across sexes in two different species without changes in sensory, sedative, depressive, and cognitive behaviors. CBD3063 is a selective, first-in-class, CRMP2-based peptidomimetic small molecule, which allosterically regulates Ca v 2.2 to achieve analgesia and pain relief without negative side effect profiles. In summary, CBD3063 could potentially be a more effective alternative to GBP for pain relief.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chronic PainPeptidomimeticsRatsAnimalsRats, Sprague-DawleyCalciumCalcium Channels, N-TypeSensory Receptor CellsGanglia, Spinal

Stichwörter der Autor:innen

Cav2.2analgesiachronic painelectrophysiologypeptidomimetic

Substanzen

PeptidomimeticsCalciumCalcium Channels, N-Type

Autor:innen und Institutionen

  • Department of Molecular Pathobiology, College of Dentistry, New York University, New York, NY 10010.
  • New York University Pain Research Center, New York, NY 10010.
  • Department of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, PA 15261.
  • Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724.
  • Department of Anesthesiology, Perioperative Care and Pain Medicine, New York University Grossman School of Medicine, New York, NY 10016.
  • Interdisciplinary Pain Research Program, New York University Langone Health, New York, NY 10016.

ORCID-Profile: Kimberly Gomez, Aida Calderon-Rivera, Sara Hestehave, Erick J Rodríguez Palma, Paz Duran, Elaine Zhu, Upasana Kumar, Eda Koseli, Bryan McKiver, Kufreobong E Inyang, Handoko, Paramjit S Arora, Marcel Patek, May Khanna, Huijuan Hu, Geoffroy Laumet, Olga A Korczeniewska, Carlos J Camacho, Rajesh Khanna

Förderung

  • NIGMS NIH HHS
  • NINDS NIH HHS
  • NCI NIH HHS
  • NIDA NIH HHS
  • HHS | NIH | National Institute of Neurological Disorders and Stroke
  • HHS | NIH | National Institutes of Drug Abuse
  • NIGMS
  • HHS | NIH | National Cancer Institute

Zitieren

APA

Gomez, K., Santiago, U., Nelson, T. S., Allen, H. N., Calderon-Rivera, A., Hestehave, S., Rodríguez Palma, E. J., Zhou, Y., Duran, P., Loya-Lopez, S., Zhu, E., Kumar, U., Shields, R., Koseli, E., McKiver, B., Giuvelis, D., Zuo, W., Inyang, K. E., Dorame, A., …, & Khanna, R. (2023). A peptidomimetic modulator of the Ca V 2.2 N-type calcium channel for chronic pain. Proceedings of the National Academy of Sciences, 120(47). https://doi.org/10.1073/pnas.2305215120

Vancouver

Gomez K, Santiago U, Nelson TS, Allen HN, Calderon-Rivera A, Hestehave S, et al. A peptidomimetic modulator of the Ca V 2.2 N-type calcium channel for chronic pain. Proceedings of the National Academy of Sciences. 2023;120(47). doi:10.1073/pnas.2305215120

BibTeX
@article{Gomez2023,
  author = {Gomez, Kimberly and Santiago, Ulises and Nelson, Tyler S and Allen, Heather N and Calderon-Rivera, Aida and Hestehave, Sara and Rodríguez Palma, Erick J and Zhou, Yuan and Duran, Paz and Loya-Lopez, Santiago and Zhu, Elaine and Kumar, Upasana and Shields, Rory and Koseli, Eda and McKiver, Bryan and Giuvelis, Denise and Zuo, Wanhong and Inyang, Kufreobong E and Dorame, Angie and Chefdeville, Aude and Ran, Dongzhi and Perez-Miller, Samantha and Lu, Yi and Liu, Xia and Handoko and Arora, Paramjit S and Patek, Marcel and Moutal, Aubin and Khanna, May and Hu, Huijuan and Laumet, Geoffroy and King, Tamara and Wang, Jing and Damaj, M Imad and Korczeniewska, Olga A and Camacho, Carlos J and Khanna, Rajesh},
  title = {A peptidomimetic modulator of the Ca V 2.2 N-type calcium channel for chronic pain},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2023},
  volume = {120},
  number = {47},
  doi = {10.1073/pnas.2305215120}
}
Kostenlos starten →